{
  "id": 5740691,
  "title": "AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic",
  "url": "https://urgent.news/2026/09/05/abbvie-allied-adarx-aims-for-ipo-with-3-drugs-in-the-clinic",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-05T07:42:51.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/abbvie-allied-adarx-aims-for-ipo-with-3-drugs-in-the-clinic/"
  },
  "original_language": "en",
  "account": null,
  "summary": "RNA interference company ADARx Pharmaceuticals revealed its intentions to go public in a Friday night SEC filing, trying to take advantage of the industry's IPO momentum. The San Diego biotech plans to list on the ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}